Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance.
High-density lipoprotein (HDL) cholesterol and its apolipoproteins each capture unique lipid and cardiometabolic information important to risk quantification. It was hypothesized that metabolic factors, including insulin resistance and type 2 diabetes, would confound the association of HDL cholesterol with coronary artery calcification (CAC) and that apolipoprotein A-I (apoA-I) and/or apolipoprotein A-II (apoA-II) would add to HDL cholesterol in predicting CAC. Two community-based cross-sectional studies of white subjects were analyzed: the Penn Diabetes Heart Study (PDHS; n = 611 subjects with type 2 diabetes, 71.4% men) and the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA; n = 803 subjects without diabetes, 52.8% men) using multivariable analysis of apoA-I, apoA-II, and HDL cholesterol stratified by diabetes status. HDL cholesterol was inversely associated with CAC after adjusting for age and gender in whites with type 2 diabetes (tobit ratio for a 1-SD increase in HDL cholesterol 0.58, 95% confidence interval [CI] 0.44 to 0.77, p <0.001) as well as those without diabetes (tobit ratio 0.72, 95% CI 0.59 to 0.88, p = 0.001). In contrast, apoA-I was a weaker predictor in subjects with (tobit ratio 0.64, 95% CI 0.45 to 0.90, p = 0.010) and without (tobit ratio 0.79, 95% CI 0.66 to 0.94, p = 0.010) diabetes, while apoA-II had no association with CAC. Control for metabolic variables, including triglycerides, waist circumference, and homeostasis model assessment of insulin resistance, attenuated these relations, particularly in subjects without diabetes. In likelihood ratio test analyses, HDL cholesterol added to apoA-I, apoA-II, and atherogenic apolipoprotein B lipoproteins but improved CAC prediction over metabolic factors only in subjects with diabetes. In conclusion, HDL cholesterol outperformed apoA-I and apoA-II in CAC prediction, but its association with CAC was attenuated by measures of insulin resistance.
Cardiovascular Institute, University of Pennsylvania Medical Center, Philadelphia, USA.
Seth S
SS
Martin
Atif N
AN
Qasim
Megan
M
Wolfe
Caitlin
C
St Clair
Stanley
S
Schwartz
Nayyar
N
Iqbal
Mark
M
Schutta
Roshanak
R
Bagheri
Nehal N
NN
Mehta
Daniel J
DJ
Rader
Muredach P
MP
Reilly
D000328:Adult; D016632:Apolipoprotein A-I / Q000097:blood*; D002114:Calcinosis / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood*; D003331:Coronary Vessels / Q000473:pathology*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D005260:Female; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged
D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D017270:Lipoprotein(a); C106575:lipoprotein A-II
Can J Cardiol. 2009 Oct;25(10):567-79
19812802
Am J Med. 1977 May;62(5):707-14
193398
Atherosclerosis. 2010 Feb;208(2):305-16
19596329
Biochemistry. 1971 Aug 31;10(18):3436-42
5000816
BMJ. 2009 Feb 16;338:b92
19221140
Ann Intern Med. 1994 Jun 15;120(12):1012-25
8185133
Circulation. 2006 Jan 3;113(1):30-7
16365194
Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1155-61
12117731
J Am Coll Cardiol. 2008 Jun 10;51(23):2199-211
18534265
Atherosclerosis. 2004 Mar;173(1):69-78
15177125
N Engl J Med. 2007 Nov 22;357(21):2109-22
17984165
Arch Intern Med. 2009 Oct 26;169(19):1775-80
19858435
Diabetes. 2001 Apr;50(4):861-6
11289053
Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):715-22
9108785
Ann Intern Med. 2009 Jan 20;150(2):84-93
19153411
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2051-8
11742884
Lancet. 1975 Jan 4;1(7897):16-9
46338
Circulation. 2007 Oct 30;116(18):2029-35
17923573
Diabet Med. 2004 Oct;21(10):1129-34
15384961
Atherosclerosis. 1996 Mar;121(1):1-12
8678914
JAMA. 2001 May 16;285(19):2486-97
11368702
Am J Cardiol. 2001 Feb 15;87(4):406-12
11179523
Diabetes. 2009 Aug;58(8):1887-92
19491209
Arterioscler Thromb. 1993 Dec;13(12):1814-21
8241102
Circulation. 2001 Sep 4;104(10):1108-13
11535564
Circulation. 1995 Aug 1;92(3):364-70
7634450
Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K
19068318
Circulation. 1992 Jan;85(1):22-9
1728453
Diabetologia. 2006 May;49(5):937-44
16525840
Eur J Clin Invest. 2000 Nov;30(11):947-56
11114956